Phase 3 Readout
BCRX: Phase 3 Topline: A Phase 3 Study to Evaluate the Safety and Pharmacokinetics of Berotralstat Prophylaxis in Children
February 1, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- February 1, 2027
- Company
- BIOCRYST PHARMACEUTICALS INC (BCRX)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Phase 3 Study to Evaluate the Safety and Pharmacokinetics of Berotralstat Prophylaxis in Children
- Indication
- Hereditary Angioedema; Pediatric